Matritech, Inc. - MZT- Profile

Home » Directory » Pharmaceuticals & Biotechnology » Critical Therapies » Cancer » Matritech, Inc. » Profile

Website: http://www.matritech.com

Phone: +1 617 928-0820
Address:
330 Nevada Street
Newton, MASSACHUSETTS 02460

Company Description
Matritech, Inc.. The Group's principal activity is to develop, produce and distribute products for the diagnosis and potential treatment of cancer. The products are based on proprietary nuclear matrix protein technology. The Group has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. The Group has NMP22(R), NMP179(R), BladderChek(R) and Matritech(R) registered trademarks and NMP35tm, NMP48tm and NMP66tm are trademarks. The major customers of the Group include Institut Fur Klinische and Fisher. The Group operates in the United States, Japan, Europe and in other countries. Develops, manufactures and markets innovative cancer diagnostic products based on proprietary nuclear matrix protein technology
Key People
Chairman & Chief Executive Stephen D. Chubb
President & Chief Operating Officer David L. Corbet
Vice President Finance, Chief Financial Officer & Treasurer Richard A. Sandberg
Vice President, Secretary & General Counsel Patricia Randall

Related Business Topics
click here
A-Z Matritech, Inc. Provider Directory
0-9 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
M
Matritech
Matritech is a biotechnology company using proprietary nuclear matrix protein (NMP) technology to develop innovative cancer diagnostic products.
www.matritech.com
Cancer Treatment Center
Innovative Cancer Treatment from Specialized Cancer Treatment Teams!
LomaLindaHealth.org/Tumor+Treatment
Advanced Cancer Treatment
Cancer Options as of October 2009 Call Us: 1-888-447-7357
www.Issels.com
Cancer Treatment
Looking For Cancer Treatments? Find Cancer Treatments Here
NewHopeMedicalCenter.com

Overview  |  Profile  |  News  |  Quote & Financials